Awards & Advancement

NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award

Friday, September 8, 2017

Two scientists at the National Cancer Institute (NCI) will receive the 2017 Lasker-DeBakey Clinical Medical Research Award for their significant research leading to the development of human papillomavirus (HPV) vaccines. The award is the country’s most prestigious biomedical research prize, and will be presented to John T. Schiller, Ph.D., of NCI’s Center for Cancer Research (CCR), and Douglas R. Lowy, M.D., also in CCR and acting director of NCI. NCI is part of the National Institutes of Health.

[Read More]

Cmed celebrates one year anniversary of encapsia

Tuesday, September 5, 2017

Cmed announced its one-year anniversary of the launch of encapsia, an innovative cloud-based clinical data suite of Apps that helps biotech and pharma sponsors transform the way data is captured, monitored and reviewed in clinical trials. The app-based solution is now being used by eight pharma companies, including two of the top five, for a variety of EDC and direct data capture eSource clinical trials.

[Read More]

Bain Capital, Cinven to nominate Claudio Albrecht CEO and CFO of STADA

Tuesday, September 5, 2017

Bain Capital and Cinven announce their intention to nominate Claudio Albrecht as new Chief Executive Officer and Mark Keatley as new Chief Financial Officer of STADA Arzneimittel. Prior to this, the current CEO Engelbert Coster Tjeenk Willink and CFO Dr Bernhard Düttmann had announced at the STADA Annual General Meeting that they would be ready to step down from their interim positions before expiry of their contracts following the successful completion of the public takeover by Bain Capital and Cinven. In line with German Corporate Governance, the actual appointment of Claudio Albrecht and Mark Keatley will be decided upon by the Supervisory Board of STADA once its new members have been appointed by Court.

[Read More]

Clintec presented with Queens Award for Enterprise – International Trade

Tuesday, September 5, 2017

Clintec, a global full service CRO, has been presented with the Queens Award for Enterprise 2017, in the category of International Trade by Lord Provost Eva Bolander in her capacity as Lord Lieutenant. The award ceremony coincides with the company’s continued expansion, with the official opening of an additional 4327sq feet floor at Clintec’s Glasgow-based headquarters, with the additional space forming a fully dedicated center of excellence for clinical research and quality assurance capabilities.

[Read More]

Jesper Ericsson appointed new CEO of Symcel

Friday, September 1, 2017

Symcel has announced that Jesper Ericsson has joined Symcel as Chief Executive Officer—with the appointment effective immediately. Ericsson was formally Director of Marketing and Sales at BioLamina, where he was responsible for direct sales both internationally and at a global and regional distributor level. During the past 10 years, Jesper has gained broad experience of the commercialization of research-based products through his work at the Unit for Bioentrepreneurship at the Karolinska Institute, Stockholm School of Entrepreneurship and as co-founder of the Stockholm BiotechBuilders Association. He holds a Ph.D. in neuroscience from the Karolinska Institute and a MSc in medical technology from the Royal Institute of Technology in Stockholm.

[Read More]

LabCorp names Dr. Brian Caveney as enterprise-wide chief medical officer

Tuesday, August 29, 2017

LabCorp, a global life sciences company, announced that Dr. Brian Caveney, a nationally recognized health-policy expert who currently serves as chief medical officer of Blue Cross and Blue Shield of North Carolina (Blue Cross NC), will fill a newly created role as enterprise-wide chief medical officer of LabCorp, effective Sept. 25. Caveney will report to David P. King, chairman and CEO of LabCorp.

[Read More]